Lupin Looks To Next Generation In Narcolepsy With Tentative US Xywav Nod

Indian Firm Also Eligible To Move On First-Generation Xyrem – But Has Not Done So

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.